DUP 105

DuP 105 shows inhibitory activities against staphylococcal isolates and B. fragilis isolates with MIC ₉₀ s of 4 to 16 μg/mL and 16 μg/mL. DuP 105 MICs for 50% of the 216 gram-positive isolates tested (MIC ₅₀ s) range from 4.0 to 16 μg/mL.

DuP 105 administered by either the oral or the parenteral route is protective against staphylococcal and streptococcal infections in mice with the 50% effective doses of 9 to 23 mg/kg.